A second, independent study
Cervical stiffness shows potential as a novel biomarker for preterm birth, published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.
Request a quote
Pregnolia was founded in 2016, building on the PhD work of Dr. Sabrina Badir. She was part of the interdisciplinary research team at ETH Zürich and the University Hospital in Zürich that studied how the stiffness of the human uterine cervix changes during pregnancy.
The goal was to detect these changes earlier and more accurately. Today the team combines scientific, technical and medical know-how, and the Pregnolia System is CE certified and sold in selected European markets.


Cervical stiffness shows potential as a novel biomarker for preterm birth, published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.
Pregnolia secured funding from the European Innovation Council through the EIC Accelerator programme.
The first UK hospitals are preparing to introduce the Pregnolia System within the Preterm Clinical Network cohort research programme.
Pregnolia AG, Wiesenstrasse 33, 8952 Schlieren, Switzerland